PUT - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 11:31:59 28/06/2024 pm IST | ||
| 2.48 EUR | -1.20% |
|
| Current month | -22.50% | ||
| 1 month | -32.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 2.48 | -1.20% |
| 27/24/27 | 2.51 | +4.58% |
| 26/24/26 | 2.4 | +30.43% |
| 25/24/25 | 1.84 | -18.58% |
| 24/24/24 | 2.26 | -18.12% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 11:31 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU1MCB |
| ISIN | DE000VU1MCB5 |
| Date issued | 04/01/2023 |
| Strike | 338.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.9 € |
|---|---|
| Lowest since issue | 1.37 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
